{"entity":{"type":"insider","cik":"0001332948","url":"/insider/0001332948","json_url":"/insider/0001332948.json","name":"Praill Anthony Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2014-03-20","last":"2021-12-09","span_basis":"filed_date"},"name_variants":[{"name":"Praill Anthony Scott","source":"filing","n_filings":1,"first_seen":"2021-12-09","last_seen":"2021-12-09"},{"name":"Praill Scott","source":"filing","n_filings":5,"first_seen":"2014-03-20","last_seen":"2017-10-05"}],"transactions":[{"id":5365161,"accession":"0000899243-21-047520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-047520","line_url":"/filing/0000899243-21-047520#line-1","is_derivative":false,"issuer_cik":"0001332948","issuer_name":"Kintara Therapeutics, Inc.","issuer_ticker":"KTRA","issuer_name_source":null,"issuer_url":"/issuer/0001332948","owner_cik":"0001332948","owner_name":"Praill Anthony Scott","owner_display_name":"Praill Anthony Scott","owner_url":"/insider/0001332948","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28700.0,"shares_display":"28,700","price_per_share":0.677,"price_display":"0.68","price_state":"stated","total_value":19429.9,"total_display":"19,429.90","total_whole":"19,430","shares_owned_after":37186.0,"shares_owned_after_display":"37,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-09","scope":"insider"},{"id":4747757,"accession":"0001213900-17-010332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-010332","line_url":"/filing/0001213900-17-010332#line-1","is_derivative":false,"issuer_cik":"0001332948","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001332948","owner_cik":"0001332948","owner_name":"Praill Scott","owner_display_name":"Praill Scott","owner_url":"/insider/0001332948","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17500.0,"shares_display":"17,500","price_per_share":0.852,"price_display":"0.85","price_state":"stated","total_value":14910.0,"total_display":"14,910.00","total_whole":"14,910","shares_owned_after":47366.0,"shares_owned_after_display":"47,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-05","filed_date":"2017-10-05","scope":"insider"},{"id":4838491,"accession":"0001213900-17-006886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-006886","line_url":"/filing/0001213900-17-006886#line-1","is_derivative":false,"issuer_cik":"0001332948","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001332948","owner_cik":"0001332948","owner_name":"Praill Scott","owner_display_name":"Praill Scott","owner_url":"/insider/0001332948","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4167.0,"shares_display":"4,167","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":15001.2,"total_display":"15,001.20","total_whole":"15,001","shares_owned_after":29444.0,"shares_owned_after_display":"29,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-28","scope":"insider"},{"id":4282062,"accession":"0001213900-17-006200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-006200","line_url":"/filing/0001213900-17-006200#line-1","is_derivative":false,"issuer_cik":"0001332948","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001332948","owner_cik":"0001332948","owner_name":"Praill Scott","owner_display_name":"Praill Scott","owner_url":"/insider/0001332948","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":19950.0,"total_display":"19,950.00","total_whole":"19,950","shares_owned_after":25277.0,"shares_owned_after_display":"25,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-06","scope":"insider"},{"id":8076746,"accession":"0001013762-15-000731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-15-000731","line_url":"/filing/0001013762-15-000731#line-1","is_derivative":false,"issuer_cik":"0001332948","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001332948","owner_cik":"0001332948","owner_name":"Praill Scott","owner_display_name":"Praill Scott","owner_url":"/insider/0001332948","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-16","filed_date":"2015-07-16","scope":"insider"},{"id":6249159,"accession":"0001013762-14-000259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-14-000259","line_url":"/filing/0001013762-14-000259#line-1","is_derivative":false,"issuer_cik":"0001332948","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001332948","owner_cik":"0001332948","owner_name":"Praill Scott","owner_display_name":"Praill Scott","owner_url":"/insider/0001332948","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":13000.0,"total_display":"13,000.00","total_whole":"13,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-18","filed_date":"2014-03-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001498382","name":"Kintara Therapeutics, Inc.","url":"/issuer/0001498382","role":"Officer (Chief Financial Officer)","n_filings":6,"first_seen":"2014-03-20","last_seen":"2021-12-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001332948","retrieved_at":"2026-08-25T19:48:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}